Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ENDOCYTE INCFinancial_Report.xls
10-Q - 10-Q - ENDOCYTE INCv376415_10q.htm
EX-31.1 - EXHIBIT 31.1 - ENDOCYTE INCv376415_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - ENDOCYTE INCv376415_ex31-2.htm
EX-10.1 - EXHIBIT 10.1 - ENDOCYTE INCv376415_ex10-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

        I, P. Ron Ellis, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Endocyte, Inc. on Form 10-Q for the quarter ended March 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Endocyte, Inc. for the periods covered by such Quarterly Report on Form 10-Q.

 

May 12, 2014    
  /s/ P. Ron Ellis
  Name: P. Ron Ellis
  Title: President and Chief Executive Officer

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

        I, Michael A. Sherman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Endocyte, Inc. on Form 10-Q for the quarter ended March 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Endocyte, Inc. for the periods covered by such Quarterly Report on Form 10-Q.

 

May 12, 2014    
  /s/ Michael A. Sherman
  Name: Michael A. Sherman
  Title: Chief Financial Officer